指南与共识前列腺增生与排尿功能障碍

2023年欧洲泌尿外科学会指南非神经源性男性下尿路症状管理摘要

Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.
指南 / 共识 · Eur Urol · 2023-05-17

该摘要介绍2023年欧洲泌尿外科学会非神经源性男性下尿路症状管理指南。采用德尔菲技术共识方法制定推荐,基于1966至2021年结构化文献检索筛选最高确定性证据。指南涵盖评估、观察等待、行为调整、药物治疗及手术治疗的选择框架。

要点

  • 评估男性下尿路症状应注重病史、体格检查、验证症状评分、尿检、尿流率及残余尿。
  • 有夜尿或储尿期症状者应使用频率-容量图表;若前列腺癌诊断改变治疗方案则检测前列腺特异性抗原。
  • 轻度症状者可观察等待;行为调整应在治疗前或同时提供;手术保留给绝对适应证或药物失败/不愿用药者。

核心结论

  • 该指南为男性下尿路症状的管理提供了循证方法。

研究设计与样本

  • 基于1966至2021年结构化文献检索筛选最高确定性证据,采用德尔菲技术共识方法制定推荐。

主要发现

  • 评估应包括病史、体格检查、验证症状评分、尿检、尿流率、残余尿,夜尿或储尿期症状者用频率-容量图表。
  • 前列腺特异性抗原应在诊断前列腺癌会改变治疗计划时检测;尿动力学检查用于特定患者。
  • 轻度症状者为观察等待候选;行为调整应在治疗前或同时提供。
  • 药物治疗选择取决于评估发现、主要症状类型、治疗改变发现的能力及对起效速度、疗效、副作用和疾病进展的期望。
  • 手术保留给绝对适应证及药物失败或不愿接受药物治疗者,术式选择取决于患者特征、期望、偏好、术者专长及模式可及性。

关键数值与推荐

  • 药物治疗选择取决于评估发现、主要症状类型、治疗改变发现的能力及对起效速度、疗效、副作用和疾病进展的期望。
  • 手术管理分为切除、剜除、汽化及替代消融和非消融技术五部分。
  • 手术技术选择取决于患者特征、期望和偏好、术者专长及模式可及性。

临床怎么用

  • 临床评估应识别症状原因并定义临床特征和患者期望。
  • 治疗应旨在改善症状并降低并发症风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Lower urinary tract symptoms (LUTS) are common, often bothersome, and have multifactorial aetiology. OBJECTIVE: To present a summary of the 2023 version of the European Association of Urology guidelines on the management of male LUTS. EVIDENCE ACQUISITION: A structured literature search from 1966 to 2021 selected the articles with the highest certainty evidence. The Delphi technique consensus approach was used to develop the recommendations. EVIDENCE SYNTHESIS: The assessment of men with LUTS should be practical. A careful medical history and physical examination are essential. Validated symptom scores, urine test, uroflowmetry, and postvoid urine residual, as well as frequency-volume charts for patients with nocturia or predominately storage symptoms should be used. Prostate-specific antigen should be ordered if a diagnosis of prostate cancer changes the treatment plan. Urodynamics should be performed for selected patients. Men with mild symptoms are candidates for watchful waiting. Behavioural modification should be offered to men with LUTS prior to, or concurrent with, treatment. The choice of medical treatment depends on the assessment findings, predominant type of symptoms, ability of the treatment to change the findings, and the expectations to be met in terms of the speed of onset, efficacy, side effects, and disease progression. Surgery is reserved for men with absolute indications, and for patients who fail or prefer not to receive medical therapy. Surgical management has been divided into five sections: resection, enucleation, vaporisation, and alternative ablative and nonablative techniques. The choice of surgical technique depends on patient's characteristics, expectations, and preferences; surgeon's expertise; and availability of modalities. CONCLUSIONS: The guidelines provide an evidence-based approach for the management of male LUTS. PATIENT SUMMARY: A clinical assessment should identify the cause(s) of symptoms and define the clinical profile and patient's expectations. The treatment should aim to ameliorate symptoms and reduce the risk of complications.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Gravas S, Gacci M, Gratzke C, et al. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2023. PMID: 37202311. doi:10.1016/j.eururo.2023.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。